Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2

S. Hubackova, A. Kucerova, G. Michlits, L. Kyjacova, M. Reinis, O. Korolov, J. Bartek, Z. Hodny,

. 2016 ; 35 (10) : 1236-1249. [pub] 20150518

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT14461 MZ0 CEP Register

Digital library NLK
Full text - Article
Source

E-resources Online Full text

NLK ProQuest Central from 2000-01-01 to 1 year ago
Open Access Digital Library from 1997-01-01
Health & Medicine (ProQuest) from 2000-01-01 to 1 year ago
Public Health Database (ProQuest) from 2000-01-01 to 1 year ago

Cellular senescence provides a biological barrier against tumor progression, often associated with oncogene-induced replication and/or oxidative stress, cytokine production and DNA damage response (DDR), leading to persistent cell-cycle arrest. While cytokines such as tumor necrosis factor-alpha (TNFα) and interferon gamma (IFNγ) are important components of senescence-associated secretome and induce senescence in, for example, mouse pancreatic β-cancer cell model, their downstream signaling pathway(s) and links with oxidative stress and DDR are mechanistically unclear. Using human and mouse normal and cancer cell models, we now show that TNFα and IFNγ induce NADPH oxidases Nox4 and Nox1, reactive oxygen species (ROS), DDR signaling and premature senescence. Unlike mouse tumor cells that required concomitant presence of IFNγ and TNFα, short exposure to IFNγ alone was sufficient to induce Nox4, Nox1 and DDR in human cells. siRNA-mediated knockdown of Nox4 but not Nox1 decreased IFNγ-induced DDR. The expression of Nox4/Nox1 required Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling and the effect was mediated by downstream activation of transforming growth factor-beta (TGFβ) secretion and consequent autocrine/paracrine activation of the TGFβ/Smad pathway. Furthermore, the expression of adenine nucleotide translocase 2 (ANT2) was suppressed by IFNγ contributing to elevation of ROS and DNA damage. In contrast to mouse B16 cells, inability of TC-1 cells to respond to IFNγ/TNFα by DDR and senescence correlated with the lack of TGFβ and Nox4 response, supporting the role of ROS induced by NADPH oxidases in cytokine-induced senescence. Overall, our data reveal differences between cytokine effects in mouse and human cells, and mechanistically implicate the TGFβ/SMAD pathway, via induction of NADPH oxidases and suppression of ANT2, as key mediators of IFNγ/TNFα-evoked genotoxicity and cellular senescence.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028440
003      
CZ-PrNML
005      
20190703134129.0
007      
ta
008      
161005s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/onc.2015.162 $2 doi
024    7_
$a 10.1038/onc.2015.162 $2 doi
035    __
$a (PubMed)25982278
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hubáčková, Soňa $u Department of Genome Integrity, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0122006
245    10
$a IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2 / $c S. Hubackova, A. Kucerova, G. Michlits, L. Kyjacova, M. Reinis, O. Korolov, J. Bartek, Z. Hodny,
520    9_
$a Cellular senescence provides a biological barrier against tumor progression, often associated with oncogene-induced replication and/or oxidative stress, cytokine production and DNA damage response (DDR), leading to persistent cell-cycle arrest. While cytokines such as tumor necrosis factor-alpha (TNFα) and interferon gamma (IFNγ) are important components of senescence-associated secretome and induce senescence in, for example, mouse pancreatic β-cancer cell model, their downstream signaling pathway(s) and links with oxidative stress and DDR are mechanistically unclear. Using human and mouse normal and cancer cell models, we now show that TNFα and IFNγ induce NADPH oxidases Nox4 and Nox1, reactive oxygen species (ROS), DDR signaling and premature senescence. Unlike mouse tumor cells that required concomitant presence of IFNγ and TNFα, short exposure to IFNγ alone was sufficient to induce Nox4, Nox1 and DDR in human cells. siRNA-mediated knockdown of Nox4 but not Nox1 decreased IFNγ-induced DDR. The expression of Nox4/Nox1 required Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling and the effect was mediated by downstream activation of transforming growth factor-beta (TGFβ) secretion and consequent autocrine/paracrine activation of the TGFβ/Smad pathway. Furthermore, the expression of adenine nucleotide translocase 2 (ANT2) was suppressed by IFNγ contributing to elevation of ROS and DNA damage. In contrast to mouse B16 cells, inability of TC-1 cells to respond to IFNγ/TNFα by DDR and senescence correlated with the lack of TGFβ and Nox4 response, supporting the role of ROS induced by NADPH oxidases in cytokine-induced senescence. Overall, our data reveal differences between cytokine effects in mouse and human cells, and mechanistically implicate the TGFβ/SMAD pathway, via induction of NADPH oxidases and suppression of ANT2, as key mediators of IFNγ/TNFα-evoked genotoxicity and cellular senescence.
650    _2
$a translokátor adeninových nukleotidů 2 $x metabolismus $7 D033742
650    _2
$a zvířata $7 D000818
650    _2
$a stárnutí buněk $x účinky léků $7 D016922
650    _2
$a nádorové buněčné linie $7 D045744
650    12
$a poškození DNA $7 D004249
650    _2
$a enzymová indukce $x účinky léků $7 D004790
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a interferon gama $x farmakologie $7 D007371
650    _2
$a myši $7 D051379
650    _2
$a NADPH-oxidasy $x biosyntéza $x genetika $7 D019255
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a transkripční faktory STAT $x metabolismus $7 D050791
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a proteiny Smad $x metabolismus $7 D051785
650    _2
$a transformující růstový faktor beta $x metabolismus $7 D016212
650    _2
$a TNF-alfa $x farmakologie $7 D014409
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kucerova, A $u Department of Genome Integrity, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Michlits, G $u Department of Tumour Immunology, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Kyjacova, L $u Department of Genome Integrity, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Reiniš, Milan $u Department of Tumour Immunology, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0083033
700    1_
$a Korolov, O $u Department of Tumour Immunology, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Bártek, Jiří, $u Department of Genome Integrity, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic. Genome Integrity Unit, Danish Cancer Society Research Center, Copenhagen, Denmark. $d 1953- $7 xx0046271
700    1_
$a Hodný, Zdeněk $u Department of Genome Integrity, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0074117
773    0_
$w MED00003600 $t Oncogene $x 1476-5594 $g Roč. 35, č. 10 (2016), s. 1236-1249
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25982278 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20190703134319 $b ABA008
999    __
$a ok $b bmc $g 1166754 $s 953070
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 35 $c 10 $d 1236-1249 $e 20150518 $i 1476-5594 $m Oncogene $n Oncogene $x MED00003600
GRA    __
$a NT14461 $p MZ0
LZP    __
$a Pubmed-20161005

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...